TrialCirculation research2015

A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure.

Emerson C Perin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.